Green-synthesized nanocomposite shows promising effects on drug delivery and tissue repair in targeted cancer therapy, indicating medical potential.
Green-synthesized CS-Cu 2 O/ZnO NCs using S. campanulata fluid (WCF) offer 94.88% cisplatin release at 72h. They show selective A375 melanoma toxicity, low fibroblast damage, and fast wound healing, proving ideal for targeted cancer therapy and repair.
No takes yet. Share an insight, caveat, or question.
Nayak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from RSC Pharmaceutics